AlphaCognition, Inc. embarked on a research program over 10 years ago to find alternative ways of treating both Alzheimer’s and Lou Gehrig’s Disease (ALS). To date both conditions have serious unmet medical needs. Current therapies for these two diseases only treat symptoms or in the case of ALS, have a modest effect in slowing its progression.